Everself & Harvard Study: ESG Helps Patients Continue Losing Weight After Stopping GLP-1 Medications
Harvard Assistant Professor, Chair of American Society for Gastrointestinal Endoscopy's Advanced Endoscopy Committee, Everself Co-founder
Featured
Hand-picked announcements, industry insights, and research from the Everself team.
Bariendo is now Everself
Chief Executive Officer & Co-founder
Everself and Fractyl Health Plan for Potential GLP-1 Off-Ramp Program Pending FDA Approval of Revita
Chief Executive Officer & Co-founder
Study Shows ESG Weight Loss Procedure More Effective And Cheaper Than Ozempic
Harvard Professor, Inventor of ESG Stomach Tightening, Everself Co-founder
State of the Union: Weight Loss Surgery and Non-Surgical Procedures in 2024
Chief Executive Officer & Co-founder
Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Obesity Primer for the Practicing Gastroenterologist
Harvard Assistant Professor, Chair of American Society for Gastrointestinal Endoscopy's Advanced Endoscopy Committee, Everself Co-founder